Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT Activator.

Literature DB >> 33356367

Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT Activator.

Abstract

Entities: Chemical

Keywords: Editorials; atherosclerosis; cardiovascular disease; cholesterol acyltransferase; high-density lipoprotein; lecithin cholesterol acyltransferase, enzyme activators

Mesh：

Substances：

Year: 2020 PMID： 33356367 PMCID： PMC7901727 DOI： 10.1161/ATVBAHA.120.315496

Source DB: PubMed Journal: Arterioscler Thromb Vasc Biol ISSN： 1079-5642 Impact factor: 8.311

× No keyword cloud information.

21 in total

1. Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension.

Authors: J Sasaki; K Arakawa
Journal: Cardiovasc Drugs Ther Date: 1990-08 Impact factor: 3.727

2. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.

Authors: Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; Ilia V Fuki; Dominic S Ng; George H Rothblat; Daniel J Rader
Journal: Circulation Date: 2009-06-29 Impact factor: 29.690

3. Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.

Authors: Lita A Freeman; Sotirios K Karathanasis; Alan T Remaley
Journal: Curr Opin Lipidol Date: 2020-04 Impact factor: 4.776

Review 4. HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.

Authors: Robert S Rosenson; H Bryan Brewer; Philip J Barter; Johan L M Björkegren; M John Chapman; Daniel Gaudet; Daniel Seung Kim; Eric Niesor; Kerry-Anne Rye; Frank M Sacks; Jean-Claude Tardif; Robert A Hegele
Journal: Nat Rev Cardiol Date: 2017-08-10 Impact factor: 32.419

5. Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin:Cholesterol Acyltransferase in Atherosclerosis?

Authors: Cecilia Vitali; Alan T Remaley; Marina Cuchel
Journal: Circulation Date: 2018-09-04 Impact factor: 29.690

6. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.

Authors: Kelly A Manthei; Shyh-Ming Yang; Bolormaa Baljinnyam; Louise Chang; Alisa Glukhova; Wenmin Yuan; Lita A Freeman; David J Maloney; Anna Schwendeman; Alan T Remaley; Ajit Jadhav; John Jg Tesmer
Journal: Elife Date: 2018-11-27 Impact factor: 8.140

7. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.

Authors: B Föger; M Chase; M J Amar; B L Vaisman; R D Shamburek; B Paigen; J Fruchart-Najib; J A Paiz; C A Koch; R F Hoyt; H B Brewer; S Santamarina-Fojo
Journal: J Biol Chem Date: 1999-12-24 Impact factor: 5.157

8. Regulation of lecithin-cholesterol acyltransferase reaction by acyl acceptors and demonstration of its "idling" reaction.

Authors: H Czarnecka; S Yokoyama
Journal: J Biol Chem Date: 1993-09-15 Impact factor: 5.157

Review 2. Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives.

Authors: Xiuting Xu; Zikai Song; Bao Mao; Guoliang Xu
Journal: Cardiovasc Ther Date: 2022-01-10 Impact factor: 3.023

2 in total